| Clinical Guidelines |
0 |
1 |
| Hypoparathyroidism |
0 |
0.99 |
| Hyperparathyroidism |
0 |
0.98 |
| Primary Hyperparathyroidism |
0 |
0.97 |
| Osteoarthritis |
0 |
0.3 |
| Pregnancy |
0 |
0.29 |
| Arrhythmia |
0 |
0.27 |
| Renal Failure |
0 |
0.24 |
| Calcium |
0 |
0.23 |
| Nephrolithiasis |
0 |
0.2 |
| Kidney |
0 |
0.18 |
| Kidney, Ureter, and Bladder |
0 |
0.18 |
| Genomic Medicine |
0 |
0.17 |
| Renal Disease |
0 |
0.16 |
| Genetics |
0 |
0.13 |
| Patient Assessment |
0 |
0.12 |
| Parathyroid |
0 |
0.11 |
| Bone |
0 |
0.1 |
| Skeletal |
0 |
0.1 |
| Social Determinants of Health |
0 |
0.1 |
| Cataract |
0 |
0.09 |
| Health Care Quality, Access, and Evaluation |
0 |
0.08 |
| Surgery |
0 |
0.08 |
| Vitamin |
0 |
0.08 |
| Epidemiology |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Minerals |
0 |
0.05 |
| Coronary Artery Disease (CAD) |
0 |
0.04 |
| Board Certification |
0 |
0.03 |
| Breastfeeding |
0 |
0.03 |
| Canada |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Dorsum |
0 |
0.03 |
| Gland |
0 |
0.03 |
| Heart |
0 |
0.03 |
| Hypercalcemia |
0 |
0.03 |
| Hypocalcemia |
0 |
0.03 |
| Lactation |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| New York |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Osteoporosis |
0 |
0.03 |
| Preoperative |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Seizure |
0 |
0.03 |
| Spain |
0 |
0.03 |
| UK Site Content |
0 |
0.03 |